How much funding has Gelsana Therapeutics, Inc. raised?

Gelsana Therapeutics, Inc. has raised $6.0M in total funding, most recently a Seed round.

Who are Gelsana Therapeutics, Inc.'s investors?

Gelsana Therapeutics, Inc.'s investors include Innosphere Ventures, MedTech Innovator.

When was Gelsana Therapeutics, Inc. founded?

Gelsana Therapeutics, Inc. was founded in 2020.

Where is Gelsana Therapeutics, Inc. headquartered?

Gelsana Therapeutics, Inc. is headquartered in San Francisco, California, United States.

What industry is Gelsana Therapeutics, Inc. in?

Gelsana Therapeutics, Inc. operates in Medtech, Biotech, Medical Devices, Wound Care.

How many employees does Gelsana Therapeutics, Inc. have?

Gelsana Therapeutics, Inc. has 1-10 employees.

Gelsana Therapeutics, Inc.

Advanced polymer wound dressings for faster healing

San Francisco, United States · Founded 2020 · $6.0M raised

Medtech

Biotech

Medical Devices

Wound Care

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: gelsanatherapeutics.com
Total Funding: $6.0M
Last Round: $3.5M SeedMar 2026
Rounds: 5

About

GelSana Therapeutics develops advanced polymer wound dressings for improved healing of chronic and hard-to-treat wounds. Its lead product, Cleragel, is a novel hydrogel dressing that reduces inflammation, prevents bacterial adhesion, and enables sustained drug delivery — addressing diabetic ulcers and other chronic wound conditions.

Summary

Gelsana Therapeutics, Inc. is a Medtech company based in San Francisco, United States, founded in 2020. It has raised $6.0M in total across 5 rounds, most recently a $3.5M Seed round in Mar 2026. Investors include Innosphere Ventures and MedTech Innovator.